This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Zurich, CH (2013 - 2014)
- Osaka, JP (2015 - 2018)
Company Filing History:
Years Active: 2013-2018
Title: Yutaka Tanoue: Innovator in Pharmaceutical Preparations
Introduction
Yutaka Tanoue is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release preparations. With a total of 7 patents to his name, Tanoue's work has had a considerable impact on drug formulation and delivery.
Latest Patents
Among his latest patents is a sustained-release preparation that contains pioglitazone or a salt thereof as an active ingredient. This preparation demonstrates superior sustainability, showing a dissolution ratio of pioglitazone of an average of 25-58% at the 2-hour time point and 60-100% at the 4-hour time point, according to the 50 rpm USP Paddle Method using a pH 2.0 KCl/HCl buffer at 37°C as a test solution. Another notable patent is a solid pharmaceutical composition that includes a compound and a pH control agent, which enhances dissolution properties and stability.
Career Highlights
Tanoue has worked with notable companies in the pharmaceutical industry, including Takeda Pharmaceutical Company Limited and Zinfandel Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise in drug formulation and innovation.
Collaborations
Throughout his career, Tanoue has collaborated with esteemed colleagues such as Tetsuya Matsuura and Yutaka Yamagata. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Yutaka Tanoue's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patients and healthcare providers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
